U.S. Household Products Stock News

With tech and health care stocks under pressure and oil prices reacting to Middle East risk, investors are watching how large integrated energy companies respond to the latest swings in sentiment. This mix of equity pullback, higher crude prices and softer retail data has created fresh winners and laggards. This article examines three global oil producers that appear especially exposed to the current news backdrop. The stocks covered below are just a sample, and the full screen highlights 15...

Restaurant Brands International Inc. has already reported second-quarter 2026 results, with revenue rising to US$2,520 million and net income to US$507 million, alongside a declared third-quarter dividend of US$0.65 per share and completion of US$205.86 million in share repurchases under its existing buyback. The combination of sharply higher earnings per share and continued cash returns through dividends and buybacks underlines management’s emphasis on profitability and shareholder capital...

Monolithic Power Systems (MPWR) is back in focus after management raised the full year growth target for its enterprise data segment tied to AI and data center chips, alongside upbeat analyst coverage. See our latest analysis for Monolithic Power Systems. The recent raise in Monolithic Power Systems' AI linked growth target comes on top of strong momentum, with a year to date share price return of 51.23% and a one year total shareholder return of 67.69%. The 30 day share price return of 7.93%...

Earlier this week, legaltech firm Legora announced it had integrated its AI-powered agentic system with Box’s content management platform, allowing joint customers to apply Legora’s tools to sensitive documents stored within Box’s governed environment. This partnership is particularly important for Box because it extends its AI and compliance-focused offering into the legal sector, where secure document processing and rigorous governance are essential requirements. We’ll now examine how...

ImmunityBio (IBRX) stock drew fresh attention after the company appointed Dr. Jim Yong Kim as Vice Chairman, reflecting a push to deepen global partnerships and support wider access to its immunotherapy programs. See our latest analysis for ImmunityBio. The appointment of Dr. Jim Yong Kim comes after a strong run in ImmunityBio’s share price, with a year to date share price return of 292.08% and a one year total shareholder return of 225.93%. Recent momentum has been steadier, with a 30 day...

MeiraGTx Holdings (MGTX) drew fresh attention after reporting second quarter and half year 2026 results, with revenue and earnings figures that marked a clear shift from prior period losses. See our latest analysis for MeiraGTx Holdings. The earnings swing has come alongside a sharp shift in sentiment toward MeiraGTx Holdings. The share price is at US$13.77, with a 90 day share price return of 50.82%, contributing to a 1 year total shareholder return of 72.77% and a 3 year total shareholder...

Textron share performance snapshot Textron (TXT) has had mixed recent share performance, with the stock down 1.5% over the past day, 1.7% over the past week, about 4.2% over the past month, and about 0.6% over the past 3 months. See our latest analysis for Textron. At a share price of $87.65, Textron’s recent share price returns have softened over the past month, even though the year to date share price return is slightly positive and the 1 year total shareholder return of 10.95% remains...

In early August 2026, CarGurus reported second-quarter 2026 results showing sales of US$250.97 million and net income of US$49.19 million, alongside updated earnings guidance for the third quarter and full year 2026 and amendments to its long-term credit facility. Beyond the headline growth, CarGurus completed a US$204.24 million buyback program that retired 6.67% of its shares, while extending its primary revolving credit facility’s maturity to 2031 and tightening leverage-related debt...

Kura Oncology (KURA) is back in focus after its second quarter 2026 earnings showed higher revenue alongside a wider net loss, arriving just days after new scientific data on its approved menin inhibitor ziftomenib. See our latest analysis for Kura Oncology. Kura Oncology’s recent scientific update on ziftomenib and the second quarter earnings release have come alongside strong momentum in the stock, with a 7 day share price return of 14.52% and a 1 year total shareholder return of 50.80%...

Why Centene’s CFO transition matters for shareholders Centene (CNC) has set out a multi year finance leadership transition after Chief Financial Officer Drew Asher announced plans to step down at the end of 2026, with Chris Neczypor appointed as successor CFO. See our latest analysis for Centene. The CFO succession news hit a stock that has already had a strong run, with Centene’s share price returning 54.16% year to date but easing recently, shown by the 3.06% 30 day share price decline and...

AvalonBay Communities (AVB) has been removed from several S&P indices, including the S&P 500 and S&P Global benchmarks. This index exclusion is an important development for investors who track liquidity and index related trading flows. See our latest analysis for AvalonBay Communities. At a share price of $184.06, AvalonBay Communities has seen its 30 day share price return fall 4.4%, while the year to date share price return is 2%. Over the longer term, total shareholder return has been...

Why Enovix Is Suddenly on Investors’ Radar Enovix (ENVX) is back in focus after CEO Raj Talluri resigned, with CFO Ryan Benton stepping in as interim CEO and executive chairman T.J. Rodgers taking a more active operating role. See our latest analysis for Enovix. The CEO change at Enovix comes after a steep reset in sentiment, with the share price down 54.44% year to date and the 1 year total shareholder return declining 64.65%. This signals fading momentum as investors reassess execution...

Why Taboola.com Stock Is Back On Investors’ Radar Taboola.com (TBLA) has drawn fresh attention after reporting second quarter 2026 results that moved from a net loss to net income, alongside new revenue guidance for the third quarter and full year. See our latest analysis for Taboola.com. Even with Taboola.com guiding to third quarter and full year revenue ranges and reporting a move to net income in the second quarter, the share price has fallen 26.33% over the past month and 23.27% over the...

In recent coverage, Happen Bank (NASDAQ: HAPN), formerly LendingClub, was highlighted for posting year-over-year earnings-per-share growth of 51.5% and generating materially higher net margins than rival SoFi in 2026. The analysis emphasized that Happen’s tighter lending discipline and stronger profitability metrics set it apart within fintech banking, particularly against less profitable peers. Next, we’ll examine how Happen’s robust earnings growth and margin strength reshape its...

In August 2026, Oshkosh Defense, the Marine Depot Maintenance Command, and authorized manufacturer MadeHere used the AdvMFG Hub Digital Sustainment Platform to securely produce approved LVSR replacement parts in Japan and Georgia during Exercise Valiant Shield, proving they can manufacture mission-critical components near the point of need. This exercise highlights how secure digital part files and distributed manufacturing could help the Marine Corps keep vehicles operational when...

Douglas Emmett (DEI) has drawn fresh attention after filing a US$175.35 million shelf registration for 15,000,000 common shares linked to an employee stock ownership plan, following recent guidance and earnings indicating ongoing losses. See our latest analysis for Douglas Emmett. At a share price of US$11.60, Douglas Emmett has had a mixed run, with the 30 day share price return down 7.27% while the year to date share price return is up 4.79%, and the 1 year total shareholder return down...

With the U.S. Iran ceasefire now expired and markets largely calm despite higher geopolitical risk, investors are staring at a mix of vulnerability and potential opportunity. Defense and military contractors in our Global Defense and Military Contractors screener sit close to this story, as governments reassess security priorities and budgets. This article walks through 3 stocks that appear positively exposed to the current news backdrop and explains what that could mean for your...

MGIC Investment (MTG) recently reported Q2 earnings with revenue roughly matching expectations and earnings per share above analyst estimates. Management highlighted a 14.5% return on equity, and the stock gained about 1.9% following the release. See our latest analysis for MGIC Investment. For context, MGIC Investment’s share price has a 90 day share price return of 19.33% and a year to date share price return of 6.72%, while the 1 year total shareholder return is 16.69% and the 5 year total...

In August 2026, Enact Holdings, Inc. reported second-quarter 2026 results showing revenue of US$317.31 million and net income of US$174.84 million, alongside basic and diluted earnings per share from continuing operations of US$1.25, all above the prior-year period. On the same day, the company reinforced its focus on capital returns by declaring a US$0.24 per-share dividend and completing a US$155.09 million buyback program that retired 3,684,091 shares, or 2.62% of its stock. We’ll now...

Multiple August announcements around MaxLinear (MXL) products for AI data centers and new client collaborations have put the stock back in focus. Investors are weighing how this broader portfolio could influence long term fundamentals. See our latest analysis for MaxLinear. The recent product launches for AI data centers and new client collaborations have arrived during a sharp move in MaxLinear’s share price, with a 7 day share price return of 23.85% and a year to date share price return of...

TechnipFMC plc recently announced it had secured a “significant” contract, valued between US$75 million and US$250 million, from Azule Energy to design and manufacture flexible flowlines, risers, and related equipment for the West Hub Tails extension of the Block 15/06 Agogo Integrated Development. This award, which will be booked into third-quarter 2026 inbound orders, highlights TechnipFMC’s role in consolidating West Hub production through the Agogo FPSO, reinforcing demand for its core...

BBB Foods Inc. has already reported its second-quarter 2026 results, with revenue rising to MX$26,037.29 million while net loss widened to MX$386.34 million, and separately filed a US$1.53 billion shelf registration for up to 37,640,312 Class A shares related to an employee stock plan. Despite reporting losses for both the quarter and first half of 2026, the company is rapidly expanding its Mexican store base and improving cash flow, while insiders’ non-discretionary share sales to cover tax...

In August 2026, Harrow, Inc. reported second-quarter revenue of US$70.66 million versus US$63.74 million a year earlier, swung to a net loss of US$17.27 million, and reiterated its 2026 revenue guidance of US$350 million to US$365 million. Just days earlier, Harrow agreed to acquire TYRVAYA nasal spray for up to US$100 million, aiming to broaden its dry eye disease franchise with a drop-free treatment that complements its existing VEVYE offering. Next, we’ll examine how reaffirmed 2026...

Agios Pharmaceuticals (AGIO) has drawn investor focus after recent trading left the stock at a last close of $33.63. With mixed return figures across different periods, the company’s rare disease portfolio is gaining fresh attention. See our latest analysis for Agios Pharmaceuticals. Over the past year, Agios Pharmaceuticals has combined a 23.73% year to date share price return with a 21.28% 90 day share price gain, yet the 1 year total shareholder return declined 10.20%. This suggests that...